Abstract:Background: Voxel-based morphometry studies have repeatedly highlighted the presence of distributed gray matter changes in schizophrenia, but to date, it is not clear if clinically useful prognostic information can be gleaned from structural imaging. The suspected association between gray matter volume (GMV) and duration of psychotic illness, antipsychotic exposure, and symptom severity also limits the prognostic utility of morphometry. We address the question of whether morphometric information from patients with drug-naive first-episode psychosis can predict the linear trajectory of symptoms following early antipsychotic intervention using a longitudinal design. Method: Sixty-two first-episode, drug-naive patients with schizophrenia underwent brain magnetic resonance imaging scans at baseline, treated with antipsychotics, and rescanned after 1-year follow-up. Positive and Negative Syndrome Scale (PANSS) was used to assess their clinical manifestations. A multivariate approach to detect covariancebased network-like spatial components [Source Based Morphometry (SBM)] was performed to analyze the GMV. Paired t tests were used to study changes in the loading coefficients of GMV in the spatial components between two time points. The reduction in PANSS scores between the baseline (T0) and 1-year follow-up (T1) expressed as a ratio of the baseline scores (reduction ratio) was computed for positive, negative, and disorganization symptoms. Separate multiple regression analyses were conducted to predict the longitudinal change in symptoms (treatment response) using the loading coefficients of spatial components that differed between T0 and T1 with age, gender, duration of illness, and antipsychotic dose as covariates. We also tested the putative "toxicity" effects of baseline symptom severity on the GMV at 1 year using multiple regression analysis. Results: Of the 30 spatial components of gray matter extracted using SBM, loading coefficients of anterior cingulate cortex (ACC), insula and inferior frontal gyrus (IFG), superior temporal gyrus (STG), middle temporal gyrus (MTG), precuenus, and dorsolateral prefrontal cortex (DLPFC) reduced with time in patients. Specifically, the lower volume of insula and IFG at baseline predicted a lack of improvement in positive and disorganization symptoms. None of the symptom severity scores (positive, negative, or disorganization) at baseline independently predicted the reduced GMV at 1 year. Conclusions: The baseline deficit in a covariance-based network-like spatial component comprising of insula and IFG is predictive of the clinical course of schizophrenia. We do not find any evidence to support the notion of symptoms per se being neurotoxic to gray matter tissue. If judiciously combined with other available predictors of clinical outcome, multivariate morphometric information can improve our ability to predict prognosis in schizophrenia.

Increased Frontal Gray Matter Volume in Individuals with Prodromal Psychosis.

Grey Matter Volume Reduction in the Frontotemporal Cortex Associated with Persistent Verbal Auditory Hallucinations in Chinese Patients with Chronic Schizophrenia: Insights from a 3 T Magnetic Resonance Imaging Study

Altered brain activity in the bilateral frontal cortices and neural correlation with cognitive impairment in schizophrenia

Abnormal grey matter changes in first-episode antipsychotic-na?ve patients with adolescent-onset schizophrenia

Prognostic Utility of Multivariate Morphometry in Schizophrenia.

Decrease in Temporal Gyrus Gray Matter Volume in First-Episode, Early Onset Schizophrenia: an MRI Study.

Excessive interstitial free-water in cortical gray matter preceding accelerated volume changes in individuals at clinical high risk for psychosis

O6.3. PATTERNS OF GRAY MATTER ABNORMALITIES IN PATIENTS WITH FIRST-EPISODE AND TREATMENT-NAïVE SCHIZOPHRENIA

Gray matter volume alterations in first-episode drug-naïve patients with deficit and nondeficit schizophrenia

Genome-Wide Association Analysis With Gray Matter Volume As A Quantitative Phenotype In First-Episode Treatment-Naive Patients With Schizophrenia

Microstructural Cortical Gray Matter Changes Preceding Accelerated Volume Changes in Individuals at Clinical High Risk for Psychosis

Association Of Cerebral Deficits With Clinical Symptoms In Antipsychotic-Naive First-Episode Schizophrenia: An Optimized Voxel-Based Morphometry And Resting State Functional Connectivity Study

Structural and functional brain abnormalities in schizophrenia: A cross-sectional study at different stages of the disease.

Progressive Grey Matter Volume Changes in Patients with Schizophrenia over 6 Weeks of Antipsychotic Treatment and Their Relationship to Clinical Improvement

A Comparative Study of Voxel-based Morphometry in Patients with Paranoid Schizophrenia and Bipolar Mania

Hippocampal and Orbital Inferior Frontal Gray Matter Volume Abnormalities and Cognitive Deficit in Treatment-Naive, First-Episode Patients with Schizophrenia.

Gray matter volume abnormalities were associated with sustained attention in unmedicated major depression.

Differential Cortical Gray Matter Deficits in Adolescent- and Adult-Onset First-Episode Treatment-Naïve Patients with Schizophrenia

Abnormal gray matter volume and regional homogeneity of resting fMRI in patients with schizophrenia and obsessive-compulsive disorder

Mapping gray and white matter volume abnormalities in early-onset psychosis: an ENIGMA multicenter voxel-based morphometry study

Right Superior Frontal Gyrus: A Potential Neuroimaging Biomarker for Predicting Short-Term Efficacy in Schizophrenia